Andrew G. Geiser - Concepedia

Author

Andrew G. Geiser

Also Known As

A G Geiser, A GEISER, A Geiser, A. Geiser, A.G. Geiser, ANDREW G. GEISER, Andrew G Geiser, Andrew G. Geiser, Andrew Geiser

Publications

6.3K

Citations

H-Index

118

Concepts

All Affiliations

Eli Lilly (United States)National Cancer Institute National Institutes of Health University of California, Irvine

About

Andrew G. Geiser is an author at Eli Lilly (United States) specializing in medicine, cell biology, and developmental biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	34	5.1K
2	Health Sciences	6	6	768
3	Natural Sciences	3	3	168
4	Public Health	3	3	110
5	Allergy	3	3	523

Andrew G. Geiser

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. A B Kulkarni, C G Huh, Daniel M. Becker, Proceedings of the National Academy of Sciences Null MiceLymphocyte DevelopmentT-regulatory CellImmunologyPathology	1993	1.9K
Maternal Rescue of Transforming Growth Factor-β 1 Null Mice John J. Letterio, Andrew G. Geiser, Ashok B. Kulkarni, Science	1994	493
Introduction of a Normal Human Chromosome 11 into a Wilms' Tumor Cell Line Controls Its Tumorigenic Expression Bernard E. Weissman, Paul J. Saxon, Steve R. Pasquale, Science CytogeneticsCancer BiologyTumor BiologyTumorigenic ExpressionP13 Region	1987	404
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. John J. Letterio, Andrew G. Geiser, Ashok B. Kulkarni, Journal of Clinical Investigation HistocompatibilityClass IiT-regulatory CellImmunologyPathology	1996	233
Transforming Growth Factor Beta-1 in Acute Myocardial Infarction in Rats Nancy L. Thompson, Fernando Bazoberry, Edith Speir, Growth Factors Growth Factor Beta-1Left Coronary ArteryCardiomyopathyHeart FailureDevelopmental Biology	1988	231
Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. Chamelli Jhappan, Andrew G. Geiser, Edith C. Kordon, The EMBO Journal Developmental BiologyTissue DevelopmentGrowth HormoneMammary GlandMammary Physiology	1993	223
SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β knockout mice Ha V. Dang, Andrew G. Geiser, John J. Letterio, The Journal of Immunology	1995	182
Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Andrew G. Geiser, John J. Letterio, A B Kulkarni, Proceedings of the National Academy of Sciences HistocompatibilityLymphocyte DevelopmentImmunologyImmune RegulationPathology	1993	180
Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. Andrew G. Geiser, J. K. Burmester, Renée Webbink, Journal of Biological Chemistry Tumor BiologyType IiTgf-beta TreatmentType Ii ReceptorMedicine	1992	173
Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling Venkatesh Krishnan, Terry L. Moore, Leah M. Helvering, Molecular Endocrinology SclerostinSignal TransductionDevelopmental BiologyBone Morphogenic ProteinMedicine	2003	167

Page 1